Cleared Traditional

Thermo Scientific Oxoid Meropenem/Vaborbactam Disc (30µg) MEV30 (K181975) - FDA 510(k) Clearance

Class II Microbiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K181975 · Oxoid Limited (Part of Thermo Fisher Scientific) · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2018
Decision
65d
Days
Class 2
Risk

K181975 is an FDA 510(k) clearance for the Thermo Scientific Oxoid Meropenem/Vaborbactam Disc (30µg) MEV30. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Oxoid Limited (Part of Thermo Fisher Scientific) (Basingstoke, GB). The FDA issued a Cleared decision on September 27, 2018 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Oxoid Limited (Part of Thermo Fisher Scientific) devices

Submission Details

510(k) Number K181975 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 24, 2018
Decision Date September 27, 2018
Days to Decision 65 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
37d faster than avg
Panel avg: 102d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 209
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K181975.
HardyDisk AST Lefamulin 20µg (LMU20)
K192326 · Hardy Diagnostics · Sep 2019
HardyDisk AST Imipenem/relebactam 10/25µg (IMR10/25)
K191931 · Hardy Diagnostics · Jul 2019
HardyDisk AST Omadacycline 30µg (OMC30)
K183298 · Hardy Diagnostics · Jan 2019
HardyDisk AST Eravacycline 20µg (ERV20)
K182357 · Hardy Diagnostics · Sep 2018
HardyDisk AST Plazomicin 30ug (PLZ30)
K181700 · Hardy Diagnostics · Jul 2018
HardyDisk Meropenem/Vaborbactam 20/10µg (MEV30)
K172621 · Hardy Diagnostics · Oct 2017